Altimmune Stock Price

-0.17 (-1.18%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Altimmune Inc ALT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.17 -1.18% 14.20 13:53:10
Open Price Low Price High Price Close Price Prev Close
14.40 14.06 14.76 14.37
Bid Price Ask Price Spread News
14.20 14.22 0.02 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
4,381 351,534 $ 14.36 $ 5,046,373 967,760 6.88 - 35.10
Last Trade Time Type Quantity Stock Price Currency
13:53:00 100 $ 14.20 USD

Altimmune Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 545.24M 38.40M 33.45M $ 8.19M $ - -1.91 -7.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -12.00k 13.30%

more financials information »

Altimmune News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week13.1016.7012.9314.401,428,2981.108.4%
1 Month13.1616.7011.7313.531,067,3231.047.9%
3 Months16.5216.8611.3513.48958,439-2.32-14.04%
6 Months12.40524.6110.4615.141,418,6101.8014.47%
1 Year7.3535.106.8817.072,127,6306.8593.2%
3 Years0.5136.250.24510.881,373,35813.692,684.31%
5 Years7.3136.250.24510.171,085,2256.8994.25%

Altimmune Description

Altimmune Inc is a United States-based clinical-stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of liver diseases. The firm's product candidates include NasoVAX, HepTcell, ALT-801, T-COVID, and NasoShield. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.